Time Charter Equivalent (TCE) Rates -- MR tankers achieved $24,700 per day, and $24,900 per day so far in Q4 2025, with 40% ...
Press Release - With one in every 25 COP30 attendees a fossil fuel lobbyist, massive industry presence intensifies calls to protect climate negotiations from corporate capture ...
Evidence-based recommendations on lorlatinib (Lorviqua) for treating ALK-positive advanced non-small-cell lung cancer that has not been treated with an ALK inhibitor in adults. Lorlatinib is also ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from ...
Wilson raised the full-year 2025 revenue guidance to $735 million to $740 million, representing 24% to 25% year-over-year growth. He stated, "This outlook contemplates continued strong volume growth ...
Earlier this week, BetMGM, a joint venture between MGM Resorts International and Entain, announced a strong third-quarter performance, with net revenue rising 23% year-over-year and full-year guidance ...
What will your day look like in terms of health, romance, finance and fortune? Read everything here. Scorpio Money Horoscope Today Financial results will improve, and your overall performance will be ...
AUSTIN, Texas, Oct. 23, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...
A 79-year-old man was admitted to a hospital in Guangzhou, China, with progressive dyspnea and edema. Echocardiography and ...
Johnson shared that full-year 2025 adjusted EBITDA guidance has been tightened to $1.50 billion to $1.55 billion, factoring in the benefit from the legal settlement and operating results through the ...
BERLIN -- Almost half of patients with advanced ALK-positive non-small cell lung cancer (NSCLC) have lived 7 years or longer following initial treatment with the ALK inhibitor alectinib (Alecensa), an ...